Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.5, was added to the study history. The previous revision, v3.6.4, was removed from the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions, updating the historical record to the latest version. The previous entry v3.6.3 was removed as part of this update.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision v3.6.3 to the Record History and removed revision v3.6.2. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now includes an expanded footer with official site links and branding, and the record history section lists past versions and their submission dates.SummaryDifference34%

- Check73 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page now shows a new release version 'Revision: v3.6.0', replacing the previous 'v3.5.5'.SummaryDifference0.4%

- Check80 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history, replacing the previous revision v3.5.4. This reflects a minor internal update to the site's history presentation.SummaryDifference0.1%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.